(Q45795602)
Statements
A phase I study of quisinostat (JNJ-26481585), an oral hydroxamate histone deacetylase inhibitor with evidence of target modulation and antitumor activity, in patients with advanced solid tumors (English)
Balaji Venugopal
Rebecca S Kristeleit
Ruth Plummer
Adam Stewart
Nele Fourneau
Peter Hellemans
Yusri Elsayed
Steve McClue
Johan W Smit
Ann Forslund
Charles Phelps
John Camm
T R Jeffry Evans